Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Prudhon

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cardiovascular Research|July 14, 2004
Asymmetric septal hypertrophy in heterozygous cMyBP-C null miceLucie Carrier, Ralph Knöll, Nicolas Vignier, et al.
Human Molecular Genetics|September 23, 2010
A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in miceAnne-Cécile Durieux, Alban Vignaud, Bernard Prudhon, et al.
Molecular Therapy. Nucleic Acids|March 4, 2018
Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular DystrophyFeriel Azibani, Astrid Brull, Ludovic Arandel, et al.
EMBO Molecular Medicine|December 17, 2017
Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathyDelphine Trochet, Bernard Prudhon, Maud Beuvin, et al.
Annals of Neurology|October 13, 2007
Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onsetMarc Bitoun, Jorge A Bevilacqua, Bernard Prudhon, et al.
Journal of Neuropathology and Experimental Neurology|August 23, 2013
Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disordersEdoardo Malfatti, Montse Olivé, Ana Lía Taratuto, et al.
Human Mutation|March 8, 2012
Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathyJohann Böhm, Valérie Biancalana, Elizabeth T Dechene, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cardiovascular Research|July 14, 2004
Asymmetric septal hypertrophy in heterozygous cMyBP-C null miceLucie Carrier, Ralph Knöll, Nicolas Vignier, et al.
Human Molecular Genetics|September 23, 2010
A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in miceAnne-Cécile Durieux, Alban Vignaud, Bernard Prudhon, et al.
Molecular Therapy. Nucleic Acids|March 4, 2018
Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular DystrophyFeriel Azibani, Astrid Brull, Ludovic Arandel, et al.
EMBO Molecular Medicine|December 17, 2017
Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathyDelphine Trochet, Bernard Prudhon, Maud Beuvin, et al.
Annals of Neurology|October 13, 2007
Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onsetMarc Bitoun, Jorge A Bevilacqua, Bernard Prudhon, et al.
Journal of Neuropathology and Experimental Neurology|August 23, 2013
Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disordersEdoardo Malfatti, Montse Olivé, Ana Lía Taratuto, et al.
Human Mutation|March 8, 2012
Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathyJohann Böhm, Valérie Biancalana, Elizabeth T Dechene, et al.
Pageof 2